The George Institute for Global Health is a global not-for-profit medical research organization, affiliated with Peking University Health Science Center, UNSW Sydney, and Oxford University. The mission is to improve the lives of millions of people worldwide through innovative health research, and we focuses on driving big change in global health systems and strategies.
The George Institute, China is one of the four divisions (Australia, China, India and the United Kingdom) of The George Institute for Global Health. The George Institute, China specifically focuses on the health issues in China. Since its establishment in 2007, it has become a leading health research organization with over 80 staff and researchers based in Beijing in conjunction with George Clinical, the Institute’s contract-based academic clinical research organization.
INTERACT3 study officially launched
NTERACT3 has therefore been initiated as a collaboration between clinical researchers at West China Hospital (WCH), Chengdu and The George Institute (TGI), China, with Professor Chao You, senior neurosurgeon at WCH, and Professor Craig Anderson, Executive Director of TGI China, as the joint principal investigators. INTERACT3 aims to establish the effects of ‘care bundle’ involving the early use of intensive BP lowering, control of glucose and fever, and correction of anticoagulation, as compared to routine care. The study will use novel stepped wedge cluster clinical trial design to roll-out a quality improvement strategy involving the interventions across hospitals in China and overseas.